29.68
price down icon0.76%   -0.31
 
loading
전일 마감가:
$29.99
열려 있는:
$30.42
하루 거래량:
445.17K
Relative Volume:
0.36
시가총액:
$3.06B
수익:
-
순이익/손실:
$-257.60M
주가수익비율:
-8.7294
EPS:
-3.4
순현금흐름:
$-220.31M
1주 성능:
-1.80%
1개월 성능:
-11.10%
6개월 성능:
-8.79%
1년 성능:
+183.19%
1일 변동 폭
Value
$29.35
$30.85
1주일 범위
Value
$27.04
$30.85
52주 변동 폭
Value
$10.12
$47.45

다인 테라 Stock (DYN) Company Profile

Name
명칭
Dyne Therapeutics Inc
Name
전화
(781) 786-8230
Name
주소
1560 TRAPELO ROAD, WALTHAM
Name
직원
173
Name
트위터
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
DYN's Discussions on Twitter

DYN을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
DYN 29.69 3.06B 0 -257.60M -220.31M -3.40
VRTX 449.25 115.43B 10.63B -479.80M -1.35B 13.33
REGN 748.22 82.04B 13.85B 4.65B 3.32B 35.06
ARGX 588.46 35.30B 1.86B -40.29M -1.28B -4.16
ALNY 247.73 32.04B 2.09B -332.26M 16.06M -4.14
BNTX 106.50 24.89B 3.30B -501.07M 1.03B 11.54

다인 테라 Stock (DYN) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-02-27 업그레이드 Raymond James Outperform → Strong Buy
2023-02-15 개시 Oppenheimer Outperform
2023-01-26 개시 Guggenheim Buy
2022-07-20 개시 Chardan Capital Markets Buy
2022-07-12 개시 Raymond James Outperform
2020-10-12 개시 JP Morgan Overweight
2020-10-12 개시 Jefferies Buy
2020-10-12 개시 Piper Sandler Overweight
2020-10-12 개시 Stifel Buy
모두보기

다인 테라 주식(DYN)의 최신 뉴스

pulisher
06:28 AM

DYN (Dyne Therapeutics) 9-Day RSI : 49.47 (As of Nov. 21, 2024) - GuruFocus.com

06:28 AM
pulisher
Nov 19, 2024

State of New Jersey Common Pension Fund D Invests $1.59 Million in Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat

Nov 19, 2024
pulisher
Nov 18, 2024

Dyne Therapeutics director Incerti Carlo sells $474,045 in stock By Investing.com - Investing.com Canada

Nov 18, 2024
pulisher
Nov 18, 2024

Dyne Therapeutics director Incerti Carlo sells $474,045 in stock - Investing.com

Nov 18, 2024
pulisher
Nov 18, 2024

Dyne therapeutics director Jason Rhodes sells $25,884 in stock - Investing.com

Nov 18, 2024
pulisher
Nov 18, 2024

Dyne therapeutics chief scientific officer sells shares worth $80,539 - Investing.com

Nov 18, 2024
pulisher
Nov 18, 2024

Dyne Therapeutics SVP sells $77,127 in stock - Investing.com India

Nov 18, 2024
pulisher
Nov 18, 2024

Dyne therapeutics chief scientific officer sells shares worth $80,539 By Investing.com - Investing.com UK

Nov 18, 2024
pulisher
Nov 18, 2024

Dyne Therapeutics, Inc. (NASDAQ:DYN) Shares Acquired by US Bancorp DE - Defense World

Nov 18, 2024
pulisher
Nov 18, 2024

HC Wainwright Predicts Weaker Earnings for Dyne Therapeutics - MarketBeat

Nov 18, 2024
pulisher
Nov 18, 2024

Chardan Capital Expects Lower Earnings for Dyne Therapeutics - MarketBeat

Nov 18, 2024
pulisher
Nov 17, 2024

Dyne Therapeutics, Inc. (NASDAQ:DYN) Short Interest Up 9.1% in October - MarketBeat

Nov 17, 2024
pulisher
Nov 16, 2024

Dyne Therapeutics (NASDAQ:DYN) Trading Down 7.1%Time to Sell? - MarketBeat

Nov 16, 2024
pulisher
Nov 15, 2024

RA Capital Management, L.P. Expands Stake in Dyne Therapeutics I - GuruFocus.com

Nov 15, 2024
pulisher
Nov 14, 2024

Janus Henderson Group PLC's Strategic Acquisition in Dyne Therap - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

Dyne Therapeutics (NASDAQ:DYN) Shares Gap DownTime to Sell? - MarketBeat

Nov 14, 2024
pulisher
Nov 14, 2024

Deep Track Capital, LP Reduces Stake in Dyne Therapeutics Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 14, 2024

RTW INVESTMENTS, LP Expands Stake in Dyne Therapeutics Inc - GuruFocus.com

Nov 14, 2024
pulisher
Nov 13, 2024

Dyne Therapeutics Reveals Q3 Results and Trial Updates - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

Dyne Therapeutics (NASDAQ:DYN) Given Buy Rating at HC Wainwright - MarketBeat

Nov 13, 2024
pulisher
Nov 12, 2024

FMR LLC Bolsters Position in Dyne Therapeutics Inc with Signific - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

Dyne Therapeutics Inc Reports Q3 2024 EPS of -$0.96, Missing Est - GuruFocus.com

Nov 12, 2024
pulisher
Nov 12, 2024

Dyne Therapeutics Inc (DYN) Quarterly 10-Q Report - Quartzy

Nov 12, 2024
pulisher
Nov 12, 2024

Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Nov 12, 2024
pulisher
Nov 12, 2024

Dyne Therapeutics' DMD Drug Shows Promise; $723.7M Cash Position Fuels Clinical Progress | DYN Stock News - StockTitan

Nov 12, 2024
pulisher
Nov 12, 2024

We're Hopeful That Dyne Therapeutics (NASDAQ:DYN) Will Use Its Cash Wisely - Simply Wall St

Nov 12, 2024
pulisher
Nov 12, 2024

Lisanti Capital Growth LLC Has $622,000 Stock Holdings in Dyne Therapeutics, Inc. (NASDAQ:DYN) - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Dyne Therapeutics Inc. (DYN) Quarterly 10-Q Report - Quartzy

Nov 12, 2024
pulisher
Nov 11, 2024

Dyne Therapeutics' Q3 Preview: High-Risk, High-Reward Path In Muscle Diseases (NASDAQ:DYN) - Seeking Alpha

Nov 11, 2024
pulisher
Nov 10, 2024

Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Nov 10, 2024
pulisher
Nov 10, 2024

Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives $50.60 Average Price Target from Brokerages - MarketBeat

Nov 10, 2024
pulisher
Nov 08, 2024

Creative Planning Has $381,000 Holdings in Dyne Therapeutics, Inc. (NASDAQ:DYN) - Defense World

Nov 08, 2024
pulisher
Nov 07, 2024

Dyne Therapeutics to Present at Upcoming Investor Conferences - The Manila Times

Nov 07, 2024
pulisher
Nov 07, 2024

Dyne Therapeutics to Present at Three Major Healthcare Investor Conferences | DYN Stock News - StockTitan

Nov 07, 2024
pulisher
Nov 05, 2024

Dyne Therapeutics Enters Oversold Territory (DYN) - Nasdaq

Nov 05, 2024
pulisher
Nov 04, 2024

Vanguard Group Inc's Strategic Acquisition in Dyne Therapeutics Inc - GuruFocus.com

Nov 04, 2024
pulisher
Nov 02, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dyne Therapeutics, Inc.DYN - PR Newswire

Nov 02, 2024
pulisher
Nov 01, 2024

How the (DYN) price action is used to our Advantage - Stock Traders Daily

Nov 01, 2024
pulisher
Oct 24, 2024

Dyne Therapeutics (DYN) Stock Dips Amidst Financial Report Insig - GuruFocus.com

Oct 24, 2024
pulisher
Oct 24, 2024

Dyne cut to neutral by J.P. Morgan on stock's outperformance (NASDAQ:DYN) - Seeking Alpha

Oct 24, 2024
pulisher
Oct 24, 2024

Dyne Therapeutics (NASDAQ:DYN) Downgraded by JPMorgan Chase & Co. to "Neutral" - MarketBeat

Oct 24, 2024
pulisher
Oct 22, 2024

Dyne Therapeutics director Kersten Dirk sells shares totaling $475,878 - Investing.com India

Oct 22, 2024
pulisher
Oct 22, 2024

Dyne Therapeutics director Kersten Dirk sells shares totaling $475,878 By Investing.com - Investing.com South Africa

Oct 22, 2024
pulisher
Oct 21, 2024

Dyne Therapeutics (DYN) Shares Plummet Amid Market Volatility - GuruFocus.com

Oct 21, 2024
pulisher
Oct 21, 2024

Where are the Opportunities in (DYN) - Stock Traders Daily

Oct 21, 2024
pulisher
Oct 19, 2024

Dyne Therapeutics director Kersten Dirk sells $1.29 million in stock By Investing.com - Investing.com Australia

Oct 19, 2024
pulisher
Oct 18, 2024

Dyne Therapeutics, Inc. (NASDAQ:DYN) Director Dirk Kersten Sells 23,671 Shares - MarketBeat

Oct 18, 2024
pulisher
Oct 16, 2024

Dyne Therapeutics, Inc. (NASDAQ:DYN) Short Interest Update - MarketBeat

Oct 16, 2024
pulisher
Oct 16, 2024

Daily Market Movement: Dyne Therapeutics Inc (DYN) Sees a 0.84 Increase, Closing at 33.59 - The Dwinnex

Oct 16, 2024
pulisher
Oct 16, 2024

Dyne Therapeutics Inc (DYN) did well last session? - US Post News

Oct 16, 2024
pulisher
Oct 16, 2024

Dyne Therapeutics Inc (DYN) gets rating Reiterated from Chardan Capital Markets - Knox Daily

Oct 16, 2024

다인 테라 (DYN) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

다인 테라 주식 (DYN) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Incerti Carlo
Director
Nov 18 '24
Sale
28.73
16,500
474,045
0
Rhodes Jason P
Director
Nov 14 '24
Sale
33.10
782
25,884
15,962
$18.98
price up icon 1.80%
$70.68
price down icon 0.42%
$38.38
price up icon 3.49%
$369.83
price up icon 1.48%
$196.58
price up icon 0.88%
$102.64
price up icon 0.27%
자본화:     |  볼륨(24시간):